Eminent study.It was reported that thrombosis occurred.The subject was enrolled in the eminent study on (b)(6) 2018 and the index procedure was performed on the same day.The target lesion was located in the right proximal superficial femoral artery (sfa) with 75% stenosis and was 30 mm long with a proximal reference vessel diameter of 6.0 mm and distal reference vessel diameter of 6.0 mm and was classified as a tasc ii a lesion.The target lesion was treated with pre-dilatation, followed by 6 mm x 60 mm study stent was placed.Post dilatation was performed with final residual stenosis of 10%.On (b)(6) 2018, the subject was discharged with antiplatelet therapy.On (b)(6) 2022, 1524 days post index procedure, the subject presented with unknown symptoms and was diagnosed with in-stent thrombosis.The subject was recommended to undergo interventional procedure as a treatment for this event.The in-stent thrombosis was treated with thrombectomy, percutaneous transluminal angioplasty using drug coated balloon and stent implantation was performed.On (b)(6) 2022, the event was considered recovered/resolved.
|